Welcome to the website of INterface BIOmaterials B.V.

INterface BIOmaterials B.V. (founded in 2008) is an independent bioscience company with expertise in biomedical materials and medical devices. The company has a quality management system according to ISO 13485.

The company developed a proprietary new product for the embolization of uterine fibroids. The product, known as X-Spheres™, was CE certified in spring 2013.

The distinguishing unique feature of the X-Spheres™ is that the embolizing spherical microparticles are not only biocompatible but also radio-opaque. The spherical microparticles can be visualized through X-ray fluoroscopy, i.e. during the embolization procedure, and also afterwards. This feature will contribute to the efficacy and safety of embolization procedures.